Figure 6. Effects of PEDF-R–binding peptides on CRX in photoreceptors. A: Schematic illustration of the treatment protocol of wild-type mouse retinal explants with PBS (vehicle) or 20 nM of each
PEDF[H105A] (positive control), H105A peptide, and R99A peptide (negative control) for 48 h followed by CRX detection. B: Representative regions of interest (ROIs) from confocal microscopy images of retinal explant cultures. Three biological
replicates (three eyes) were used for each vehicle and PEDF[H105A] treatment, while four biological replicates (4 eyes) were
used for the R99A and H105A groups. Each condition included four technical replicates (ROIs). Mice were 3 months old. C: CRX mean fluorescence intensity (MFI) was measured within each ROI and normalized to the number of DAPI-positive nuclei;
each point represents one explant from one of three independent mice (n = 3). Data are shown as mean ± SD. Statistical significance
was determined by ordinary one-way analysis of variance multiple comparisons: ns, not significant; *p < 0.05, ***p < 0.001.
